December 2021 FDA Recall Oxycodone Hydrochloride by Lupin Pharmaceuticals Inc.
D-0358-2022 - Out-of-specification impurity test result observed at 18-month long term stability time point.

This Class III drug recall was voluntarily initiated by Lupin Pharmaceuticals Inc. on December 29, 2021 for the product Oxycodone Hydrochloride. The FDA reported the reason for recall as out-of-specification impurity test result observed at 18-month long term stability time point.. The product was distributed in Product Distributed in NY and OH. and the recall is currently terminated.

Recall Number: D-0358-2022

Reason for Recall
Out-of-specification impurity test result observed at 18-month long term stability time point.
Initiated
12-29-2021
Reported
01-12-2022
Quantity
23,965 100 count bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Lupin Pharmaceuticals Inc.
Product Distributed in NY and OH.
Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01

Batch or Lot Expiration Information

Lot# S000268, Exp. date January 2022